Session Chair Profile

M.D., M.P.H., CEO, CancerLinQ

Dr. Khozin is an oncologist and physician-scientist, currently serving as Chief Executive Officer of CancerLinQ, a company focused on advancing cancer care quality and research. Previously, he was Global Head of Data Strategy and Data Science Innovation at J&J, leading a worldwide multidisciplinary team charged with the design and implementation of pioneering data science solutions to support the development of innovative medicines. Before joining J&J, Dr. Khozin led FDA Oncology Center of Excellence’s bioinformatics, regulatory science, and clinical trial innovation efforts and was the founding Executive Director of Information Exchange and Data Transformation (INFORMED), the FDA’s first data science and technology incubator that played a pivotal role in the agency’s technology modernization efforts. Before his tenure in federal government, Dr. Khozin was the cofounder of Hello Health, a company focused on developing integrated telemedicine, point-of-care data visualization, and advanced analytical systems for optimizing patient care and clinical research.

 Session Abstract – PMWC 2022 Silicon Valley

Track 2 - June 30 9.00 A.M.-10.15 A.M.

This session outlines current challenges and opportunities related to the use of AI to advance therapeutic development and care delivery, with a special focus on medical imaging.